source
- Backed by NVIDIA, Basecamp bags $140M to advance AI-designed drugsBasecamp Research joins the growing group of AI-forward biotechs that in recent months have brought in notable sums from investors, including Isomorphic Labs and Enveda.BioSpace · 27d ago↗ source
- Roche and Ionis report Phase 3 success for RNA therapy sefaxersen in IgA nephropathyA late‑stage Phase 3 trial of the Roche‑Ionis RNA‑targeted drug sefaxersen met its primary endpoint, showing a statistically significant reduction in proteinuria for patients with primary IgA nephr…